Parkside Financial Bank & Trust’s Novavax NVAX Stock Holding History

Parkside Financial Bank & Trust’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$635	Hold	78	–	–	﹤0.01%	2494
2025 Q4	$525	Sell	78 -73	-48%	-$550	﹤0.01%	2566
2025 Q3	$1.31K	Buy	151 +73	+94%	+$568	﹤0.01%	2173
2025 Q2	$492	Buy	78 +18	+30%	+$119	﹤0.01%	2563
2025 Q1	$385	Buy	+60	New	+$496	﹤0.01%	2558
2022 Q3	–	Sell	-45	Closed	-$2K	–	1896
2022 Q2	$2K	Buy	+45	New	+$2.33K	﹤0.01%	1599
2022 Q1	–	Sell	-20	Closed	-$3K	–	1896
2021 Q4	$3K	Hold	20	–	–	﹤0.01%	1512
2021 Q3	$4K	Buy	20 +14	+233%	+$3.08K	﹤0.01%	1342
2021 Q2	$1K	Sell	6 -24	-80%	-$4.4K	﹤0.01%	1647
2021 Q1	$5K	Sell	30 -12	-29%	-$2.39K	﹤0.01%	1213
2020 Q4	$5K	Sell	42 -153	-78%	-$16.3K	﹤0.01%	1119
2020 Q3	$21K	Buy	195 +42	+27%	+$5.12K	0.01%	631
2020 Q2	$13K	Buy	+153	New	+$5.85K	﹤0.01%	753

Other funds holding NVAX

SCM

Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parkside Financial Bank & Trust's NVAX Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its Novavax (NVAX) position steady in Q1 2026 at 78 shares worth $635. The position accounts for ﹤0.01% of the portfolio, ranked #2494.

Parkside Financial Bank & Trust first reported a position in NVAX in Q2 2020 and has held it in 13 quarters since. The position peaked at $21K in Q3 2020. 258 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

Parkside Financial Bank & Trust held 78 shares of Novavax worth $635 as of Q1 2026.
Parkside Financial Bank & Trust left its Novavax share count unchanged in Q1 2026.
Novavax made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2494 holding.
Parkside Financial Bank & Trust first reported a position in Novavax in Q2 2020 and has held it in 13 quarters since.
Parkside Financial Bank & Trust's Novavax position peaked at $21K in Q3 2020.
258 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.